Abbott LaboratoriesvsProgyny

ABT and PGNY stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.45

Value $187B

-0.99%
ABT's page

PGNY

Progyny, Inc.

$37.15

Value $2.7B

+2.68%
PGNY's page

Abbott Laboratories (ABT) has a market value of $187B and Progyny (PGNY) $2.7B. Over the last year, with dividends, ABT moved -15.7% and PGNY +51.3%. The P/E is 39.7 for ABT and 30.1 for PGNY. Dividend yield: ABT 2.35%, PGNY none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    PGNY$2.7B

    ABT is 68 times PGNY

  • Revenue, 12 months

    ABT$48.2B

    PGNY$1.3B

    ABT is 36 times PGNY

  • Net income, 12 months

    ABT$4.7B

    PGNY$91M

    ABT is 52 times PGNY

  • Operating margin

    ABT13.8%

    PGNY9.4%

    4.4 points apart

  • ROIC

    ABT6.3%

    PGNY18.2%

    11.9 points apart

  • P/E

    ABT39.7

    PGNY30.1

    ABT is 1.3 times PGNY

  • Dividend yield

    ABT2.4%

    PGNY0.0%

    2.4 points apart

  • 5-year return

    ABT-8.3%

    PGNY-40.5%

    32.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.3%

PGNY-40.5%

5010020222023202420252026
Returns by period
PeriodABTWith dividendsPGNYWith dividends
1 year since November 14, 2025-15.7%Price -17.7%+51.3%Price +51.3%
3 years since November 16, 2023+14.2%+4.5% a yearPrice +7.2%+18.3%+5.8% a yearPrice +18.3%
5 years since November 15, 2021-8.3%-1.7% a yearPrice -17.0%-40.5%-9.9% a yearPrice -40.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesPGNYProgyny

Valuation

ABTPGNY
Valuation
Price$107.45$37.15
Market value$187B$2.7B
Enterprise value (EV)$214B$2.5B
P/E39.730.1
P/E, 5-year median33.749.7
P/B3.76.6
EV/EBIT32.120.2
Free cash flow yield3.6%6.6%

Results and growth

ABTPGNY
Results and growth
Revenue, 12 months$48.2B$1.3B
Net income, 12 months$4.7B$91M
Free cash flow, 12 months$6.8B$180M
Earnings per share, 12 months$2.69$1.09
Revenue growth, year on year5.7%10.4%
Revenue growth a year, past+5.1%over 5 years+30.2%over 5 years
EPS growth a year, past+8.3%over 5 years+6.7%over 5 years

Margins and returns on capital

ABTPGNY
Margins and returns on capital
Gross margin56.9%24.9%
Operating margin13.8%9.4%
Net margin9.8%6.8%
ROIC6.3%18.2%
ROE9.1%19.1%

Balance sheet

ABTPGNY
Balance sheet
Cash$4.3B$196M
Total debt$31.2B$26M
Net debt / EBITDA3.3-1.5
Interest cover6.7×–

Dividends and buybacks

ABTPGNY
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%3.0%
Shareholder yield2.8%3.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or PGNY

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Progyny?

By market value, Abbott Laboratories ($187B) is about 68.2 times Progyny ($2.7B), at today's prices.

How did ABT and PGNY stock do over the last 5 years?

Since November 15, 2021, ABT's price moved -17.0% and PGNY's -40.5%. With dividends: ABT -8.3% (-1.7% a year), PGNY -40.5% (-9.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or PGNY?

The dividend yield at today's price is 2.35% for Abbott Laboratories and none for Progyny. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and PGNY?

At today's price, the P/E is 39.7 for ABT and 30.1 for PGNY. The median of the last five years was 33.7 and 49.7, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Progyny?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 6.8% for Progyny, and the operating margin 13.8% and 9.4%. Revenue was $48.2B and $1.3B.

Which is the better investment, Abbott Laboratories or Progyny?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.